Emma Titmuss

947 total citations
21 papers, 104 citations indexed

About

Emma Titmuss is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Emma Titmuss has authored 21 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Emma Titmuss's work include Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Emma Titmuss is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Emma Titmuss collaborates with scholars based in Canada, United States and United Kingdom. Emma Titmuss's co-authors include Steven J.M. Jones, Janessa Laskin, Marco A. Marra, Daniel J. Renouf, Ian Jacobs, Geoffrey M. Curran, J. H. Shepherd, Erin Pleasance, Michael Sheaff and Jo-Anne Chin Aleong and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Emma Titmuss

17 papers receiving 100 citations

Peers

Emma Titmuss

ONCOL

Eugenia Ortega Spain

E. Salinas United States

Roi Tschernichovsky Israel

Dennis Mauricio United States

Giorgia Trevisan United Kingdom

Lisa Richters Germany

Ioannis Kotsopoulos United Kingdom

Maria Pilar Barretina-Ginesta Spain

Vydmantas Atkočius Lithuania

Daliah Tsoref Israel

Eugenia Ortega Spain

Emma Titmuss

44 ×1.0

ONCOL

42 ×1.2

36 ×1.2

25 ×1.1

20 ×1.2

Citations per year, relative to Emma Titmuss Emma Titmuss (= 1×) peers Eugenia Ortega

Countries citing papers authored by Emma Titmuss

Since Specialization

Citations

This map shows the geographic impact of Emma Titmuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Titmuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Titmuss more than expected).

Fields of papers citing papers by Emma Titmuss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Titmuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Titmuss. The network helps show where Emma Titmuss may publish in the future.

Co-authorship network of co-authors of Emma Titmuss

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Titmuss. A scholar is included among the top collaborators of Emma Titmuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Titmuss. Emma Titmuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Titmuss, Emma, Fábio C. P. Navarro, Charles W. Abbott, et al.. (2025). Identifying the optimal post-surgical timing of molecular residual disease (MRD) detection in colorectal cancer (CRC) using an ultra-sensitive assay: Interim results from the VICTORI study.. Journal of Clinical Oncology. 43(4_suppl). 275–275.

Loree, Jonathan M., Emma Titmuss, Carl J. Brown, et al.. (2025). Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial (CCTG CO.28).. Journal of Clinical Oncology. 43(4_suppl). 20–20.

Titmuss, Emma, Robert J. Vanner, David F. Schaeffer, et al.. (2024). Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors. Cancer Research Communications. 5(1). 66–73. 2 indexed citations

Titmuss, Emma, Dongsheng Tu, Stephanie Yasmin Brule, et al.. (2024). Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials. Clinical Cancer Research. 30(6). 1121–1130. 3 indexed citations

Loree, Jonathan M., Emma Titmuss, James T. Topham, et al.. (2024). Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical Cancer Research. 30(15). 3189–3199. 11 indexed citations

Titmuss, Emma, Irene Yu, Erin Pleasance, et al.. (2024). Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors. Current Oncology. 31(4). 1865–1875. 1 indexed citations

Titmuss, Emma, James T. Topham, David F. Schaeffer, et al.. (2024). Clonal hematopoiesis of indeterminate potential (CHIP), treatment outcomes and adverse events in gastrointestinal cancers: A pooled analysis of clinical trial and real-world data.. Journal of Clinical Oncology. 42(3_suppl). 169–169.

Titmuss, Emma, Fábio C. P. Navarro, Charles W. Abbott, et al.. (2024). Circulating tumor DNA (ctDNA) kinetics in colorectal cancer (CRC) treated with curative intent in the VICTORI study with an ultrasensitive MRD assay.. Journal of Clinical Oncology. 42(16_suppl). e15625–e15625.

Yeung, Cynthia, Emma Titmuss, Dongsheng Tu, et al.. (2024). Impact of concurrent antibiotics on survival with immunotherapy in metastatic colorectal and pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). 2609–2609. 1 indexed citations

10.

Romero, Joan Miguel, Emma Titmuss, Yifan Wang, et al.. (2023). Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers. npj Precision Oncology. 7(1). 73–73. 8 indexed citations

11.

Tsang, Erica S., Veronika Csizmók, Laura M. Williamson, et al.. (2023). Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration. npj Precision Oncology. 7(1). 31–31. 11 indexed citations

12.

Titmuss, Emma, Katy Milne, Martin Jones, et al.. (2023). Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. International Journal of Molecular Sciences. 24(6). 5869–5869. 2 indexed citations

13.

Titmuss, Emma, Alexandra Pender, James T. Topham, et al.. (2022). The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space. Journal of Molecular Diagnostics. 24(6). 609–618. 7 indexed citations

14.

Titmuss, Emma, Richard Corbett, Scott Davidson, et al.. (2022). TMBur: a distributable tumor mutation burden approach for whole genome sequencing. BMC Medical Genomics. 15(1). 190–190. 4 indexed citations

15.

Romero, Joan Miguel, Emma Titmuss, Yifan Wang, et al.. (2022). Assessment of a 4-chemokine signature in prediction of T-cell inflammation and response to immune checkpoint inhibition across tumor types.. Journal of Clinical Oncology. 40(16_suppl). 2558–2558. 1 indexed citations

16.

Wee, Kathleen, Laura Williamson, Emma Titmuss, et al.. (2022). Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysis. Melanoma Research. 32(4). 278–285. 2 indexed citations

17.

Zhang, Yiqun, Fengju Chen, Erin Pleasance, et al.. (2021). Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapy. Cell Reports. 37(7). 110023–110023. 13 indexed citations

18.

Weymann, Deirdre, Samantha Pollard, Emma Titmuss, et al.. (2021). Clinical and cost outcomes following genomics‐informed treatment for advanced cancers. Cancer Medicine. 10(15). 5131–5140. 9 indexed citations

19.

Mendis, Shehara, James T. Topham, Emma Titmuss, et al.. (2019). Comprehensive transcriptome analysis reveals link between epigenetic dysregulation, endogenous retrovirus expression and immunogenicity in metastatic colorectal carcinoma.. Journal of Clinical Oncology. 37(15_suppl). 3535–3535. 4 indexed citations

20.

Titmuss, Emma, Jo-Anne Chin Aleong, Michael Sheaff, et al.. (2004). A review of post‐trachelectomy isthmic and vaginal smear cytology. Cytopathology. 15(2). 97–103. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact